Currently, were not doing that
"With EYDENZELT demonstrating biosimilarity to its reference product, we believe this approval will mark a significant milestone in the treatment landscape of retinal diseaseshelping physicians broaden their options and improving patient outcomes." #Ophthalmology #Biosimilars #FDAApproval #RetinalDiseases #InnovationInHealthcare #Celltrion #EYDENZELT To view or add a comment, sign in #MASH and the #Latest Therapeutic Breakthrough,August 2025 Metabolic dysfunction associated steatohepatitis (MASH): is a #progressive form of fatty liver disease driven by #obesity, #insulin resistance, and #metabolic syndrome
Repeat scans were performed in all subjects who completed 52 weeks of treatment
When to Seek Help: Watch for symptoms like neck lumps or difficulty swallowing
If you are ready to try a skin-lightening IV drip, let Amax guide you to the right expert
It highlights how these peptides stimulate growth hormone (GH) production, which is crucial for deep sleep, recovery, and overall wellness